À venirEU Funding & Tenders portal
Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
European Commission · Horizon Europe Framework Programme (HORIZON)
Expected Outcome: Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes: Patients with rare or very rare cancers or…
- Clinical Research
- Common Cancers
- High Income Countries
- Oncology Nurses
- Precision Oncology
16 sept. 2027
Environ 11 mois restants
3 000 000 € – 10 M € par subvention